BCS: Measurements of solubility and permeability
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Presentation
- By: POLLI, James (U of Maryland School of Pharmacy, Pharmaceutical Sciences, Baltimore, MD, United States of America)
The BCS allows for the waiver of in vivo bioequivalence studies for certain IR products, by considering solubility, permeability, and drug product dissolution. The objective of this presentation is to discuss methodological approaches to measure solubility, permeability, and dissolution to BCS classify a drug, including literature sources and in.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.